SCHEMBL6791986

SCHEMBL6791986

Cc1cc(F)cc2c(=O)c3c(cnn3C)[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.37
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
HTT P42858 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
TNKS O95271 3/20 0.32
PARP1 P09874 2/20 0.32
TNKS2 Q9H2K2 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784909 0.86 ABCB1 (0.51) ABCB1HSD17B10ALDH1A1KDM4EGLA
SCHEMBL6785080 0.81 ABCB1 (0.37) ABCB1HSD17B10ALDH1A1KDM4EGLA
SCHEMBL6786900 0.78 KDM4E (0.51) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6785897 0.77 DAO (0.35) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6787155 0.77 DAO (0.38) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6787376 0.76 DAO (0.38) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6792539 0.76 GRIN2D (0.36) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6783202 0.75 FEN1 (0.42) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6787118 0.74 MPO (0.38) HSD17B10ALDH1A1KDM4EGLAGAA
SCHEMBL6781574 0.74 FEN1 (0.41) HSD17B10ALDH1A1KDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG ABCB1 2754/4885HSD17B10 3513/4885ALDH1A1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.